You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Platinum-Sensitive Recurrent Ovarian Cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer Trial in Napoli (Olaparib tablets)

Recruiting
  • BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
  • Olaparib tablets
  • Napoli, Italy
    Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento
Mar 3, 2021

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Epithelial Ovarian Cancer Trial in Singapore (Oregovomab, Nivolumab, Chemotherapy)

Unknown status
  • Epithelial Ovarian Cancer
  • Singapore, Singapore
  • +1 more
Nov 30, 2021

Variance of HRD From Paired Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • +2 more
    • Nanjing, Jiangsu, China
      Xiaoxiang Chen
    Sep 25, 2021

    Ovarian Cancer, Fallopian Tubes Cancer, Peritoneal Cancer Trial in United States (Secondary Cytoreductive Surgery, Carboplatin

    Active, not recruiting
    • Ovarian Cancer
    • +2 more
    • Secondary Cytoreductive Surgery
    • +2 more
    • Hartford, Connecticut
    • +10 more
    Feb 23, 2022

    Recurrent Ovarian Carcinoma Trial in Austria

    Recruiting
    • Recurrent Ovarian Carcinoma
      • Graz, Austria
      • +8 more
      Sep 1, 2021

      Ovarian Cancer Trial in Changsha (Doxorubicin Hydrochloride Liposome Injection+carboplatin, paclitaxel +carboplatin)

      Recruiting
      • Ovarian Cancer
      • Doxorubicin Hydrochloride Liposome Injection+carboplatin
      • paclitaxel +carboplatin
      • Changsha, Hunan, China
        Hunan Cancer Hospital
      Apr 7, 2021

      Ovarian Cancer, Ovarian and Fallopian Tube Cysts and Tumors, Tumors by Site Trial in Nanjing (Anlotinib, Olaparib)

      Recruiting
      • Ovarian Cancer
      • +18 more
      • Nanjing, Jangsu, China
        JiangSu Cancer Hospital
      Oct 29, 2020

      Ovarian Cancer Trial in Beijing (Paclitaxel (albumin-bound))

      Not yet recruiting
      • Ovarian Cancer
      • Paclitaxel (albumin-bound)
      • Beijing, Beijing, China
        National Cancer Center/ National Clinical Research Center for Ca
      Dec 8, 2020

      Ovarian Tumors, Carcinoma, Ovarian Epithelial, Tumor of Stomach Trial (Pembrolizumab, Lenvatinib)

      Not yet recruiting
      • Ovarian Neoplasms
      • +7 more
      • (no location specified)
      Aug 17, 2020

      Prevalence of BRCA in Patients With Ovarian Cancer

      Completed
      • BRCA Status
      • Ovarian Cancer
      • Testing of BRCA status regarding germline and somatic mutation
      • Berlin, Germany
      • +19 more
      Jun 11, 2021

      Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

      Not yet recruiting
      • Ovarian Cancer Recurrent
      • Fluzopril Combined With Apatinib
      • (no location specified)
      Oct 22, 2023

      Peritoneal Carcinomatosis, Ovarian Cancer Trial in Belgium, Germany, Norway (Radspherin)

      Recruiting
      • Peritoneal Carcinomatosis
      • Ovarian Cancer
      • Leuven, Belgium
      • +3 more
      Sep 3, 2021

      Ovarian Tumors Trial in Canada, United States (Sagopilone (ZK 219477) + carboplatin)

      Completed
      • Ovarian Neoplasms
      • Sagopilone (ZK 219477) + carboplatin
      • Tucson, Arizona
      • +15 more
      Apr 6, 2021

      Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Bronx, New York

      Completed
      Has Results
      • Recurrent Fallopian Tube Carcinoma
      • +2 more
      • Bronx, New York
      • +2 more
      Oct 18, 2021

      Ovarian Cancer Recurrent Trial in Czechia (DCVAC/OvCa, Standard of Care Chemotherapy)

      Completed
      • Ovarian Cancer Recurrent
      • DCVAC/OvCa
      • Standard of Care Chemotherapy
      • Brno, Czechia
      • +7 more
      Apr 20, 2021

      Relapsed Ovarian Cancer Trial (Fluzoparib, Apatinib)

      Not yet recruiting
      • Relapsed Ovarian Cancer
      • (no location specified)
      Oct 7, 2023

      Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

      Completed
      • Ovarian Cancer
      • Manchester, United Kingdom
        The Christie NHS Foundation Trust
      Feb 4, 2022

      Patients With Platinum Sensitive Recurrent Ovarian Cancer

      Completed
      • Epithelial Ovarian Cancer
      • +2 more
      • Santiago De Compostela, A Coruña, Spain
      • +56 more
      Aug 4, 2021

      Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 Trial in Worldwide (APR-246, Carboplatin and

      Completed
      Has Results
      • Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
      • APR-246
      • Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
      • Los Angeles, California
      • +54 more
      Sep 20, 2022

      Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)

      Recruiting
      • Ovarian Cancer Recurrent
      • Beijing, China
        Cancer Hospital Chinese Academy of Medical Science and Peking Un
      Aug 23, 2023

      Ovarian Tumors, Ovarian Diseases Trial (Adebrelimab, Fuzuloparib)

      Not yet recruiting
      • Ovarian Neoplasms
      • Ovarian Diseases
      • (no location specified)
      Feb 23, 2023

      Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

      Not yet recruiting
      • Platinum-Resistant Fallopian Tube Carcinoma
      • +5 more
      • Biopsy
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Jan 3, 2023

      Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

      Not yet recruiting
      • Platinum-resistant Ovarian Cancer
      • Oral Topotecan Combined With Anlotinib
      • Shanghai, China
        Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
      Feb 12, 2023